LivingGLP1
Study S001250

Exploring the Neural Substrates of Cognitive Dysfunction With Glucagon-like Peptide-1 Agonists

Registration

Registration
NCT02423824
Acronym
COGDYS-GLP1
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE3
Masking
NONE
Status
COMPLETED
Enrollment
21
Start
2015-05
Primary completion
2016-04
Lead sponsor
University Health Network, Toronto
Conditions
Bipolar Disorder; Major Depressive Disorder
Interventions
BIOLOGICAL:Liraglutide
Results posted
FALSE

Registered primary outcomes

  • Executive function [4 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.